IN BRIEF: Genedrive receives Indian import license for Covid test kit

Fri, 25th Jun 2021 14:39

Genedrive PLC - Manchester, England-based molecular diagnostics firm - Confirms it has received license to import its SARS-CoV-2 kit into India via its partner DIVOC Health. Genedrive received approval from the Indian Council of Medical Research for its Covid testing kit back in April.

Genedrive's 96 SARS-CoV-2 Kit is designed to detect active infection in Covid patients and eliminates the need for cold temperature storage, making it ideal for high temperature countries such as India.

Current stock price: 55.87 pence, up 13% on Friday

Year-to-date change: up 15%

By Will Paige; willpaige@alliancenews.com

Related Shares

More News

24 Apr 2024 17:26

Genedrive enters clinical trial deal in US for MT-RNR1 US approval

(Alliance News) - Genedrive PLC on Wednesday said it has entered into a clinical trial agreement to support clinical studies to progress the regulator...

3 Apr 2024 16:54

LONDON MARKET CLOSE: FTSE 100 up thanks to US economic data

(Alliance News) - Stock prices in London closed mostly higher on Wednesday, after some data from the US reinforced the interest rate cut trajectory ac...

3 Apr 2024 13:54

Genedrive shares jump on NICE test recommendation

(Sharecast News) - Genedrive shares were surging on Wednesday, after it received a significant endorsement from the UK's National Institute for Health...

3 Apr 2024 11:49

Genedrive shares surge as UK's NICE backs test for ischaemic stroke

(Alliance News) - Genedrive PLC on Wednesday praised the National Health Service's work on strokes and mini strokes as a test by the company received ...

3 Apr 2024 10:47

AIM WINNERS & LOSERS: UK NICE backs Genedrive test; Corero renews deal

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.